Page 4«..3456..1020..»

You are currently browsing the Nano Medicine category

Immune Repertoire Sequencing Market Report Outlining the Current State of the Market by 2020-2027 Along with Key Players Junom Therapeutics, Roche…

§ May 23rd, 2020 § Filed under Nano Medicine Comments Off on Immune Repertoire Sequencing Market Report Outlining the Current State of the Market by 2020-2027 Along with Key Players Junom Therapeutics, Roche…

Immune Repertoire Sequencing Market is a comprehensive report on the global market provides in-depth insight into the industry covering all the important parameters and analyzes that provide qualitative insight into the factors that affect Global Immune Repertoire Sequencing Market growth. Includes all regions and countries in the world that show regional development status including market size.

Global Immune Repertoire Sequencing Market research report has published by HealthCare Intelligence Markets and it is an effective data source for the readers. It offers widespread information on the Global Immune Repertoire Sequencing Market. The purpose of this study is to define the overview of the global market with respect to market size, shares, sales patterns, and pricing structures. Primary and secondary research refers to collect the desired data of the target market.

Ask for Sample Copy of This Report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=140942

Top Key Players Included in This Report:

Junom Therapeutics, Roche Holding, Illumina, ThermoFisher Scietific, Pacific Biosciences, CD Genomics

The research objectives of this report are as follows:

Get Discount on This Report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=140942

The report also summarized the high revenue generated with market facts and figures across regions such as North America, Japan, Europe, Asia, and India. We focus on the key issues needed to have a positive impact on the market, such as policy, international trade, and speculation, and supply-demand in the Global Immune Repertoire Sequencing Market.

This market research report on the Global Immune Repertoire Sequencing Market is a comprehensive study of industry-specific frameworks, industry-strength drivers, and manacles. Over the next seven years, we will provide market forecasts for the future. The study also provides markets for sectors such as end-users, industries and size.

The report also covers in-depth explanations, competitive scenarios, and a broad product portfolio with a broad product portfolio of key players in the Global Immune Repertoire Sequencing Market and SWOT analysis adopted by competitors. This report provides Porter analysis, PESTEL analysis, and market appeal to help you better understand macro and microscopic market scenarios.

If You Have Any Query, Ask Our Experts: https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=140942

Table of Contents:

Chapter 1: Global Immune Repertoire Sequencing Market Overview Chapter 2: Global Economic Impact on Industry Chapter 3: Production, Revenue (Value) by Region Chapter 4: Supply (Production), Consumption, Export, Import by Regions Chapter 5: Production, Revenue (Value), Price Trend by Type Chapter 6: Global Immune Repertoire Sequencing Market Analysis by Application Chapter 7: Manufacturing Cost Analysis Chapter 8: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 9: Marketing Strategy Analysis, Distributors/Traders Chapter 10: Market Effect Factors Analysis Chapter 11: Global Immune Repertoire Sequencing Market Forecast

Here is the original post:
Immune Repertoire Sequencing Market Report Outlining the Current State of the Market by 2020-2027 Along with Key Players Junom Therapeutics, Roche...

Read the Rest...

How Coronavirus Pandemic Will Impact Radiopharmaceuticals in Nuclear Medicine Market 2020 Increasing Demand, Growth Analysis and Future Outlook by…

§ May 23rd, 2020 § Filed under Nano Medicine Comments Off on How Coronavirus Pandemic Will Impact Radiopharmaceuticals in Nuclear Medicine Market 2020 Increasing Demand, Growth Analysis and Future Outlook by…

The report on the Radiopharmaceuticals in Nuclear Medicine market provides a birds eye view of the current proceeding within the Radiopharmaceuticals in Nuclear Medicine market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Radiopharmaceuticals in Nuclear Medicine market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Radiopharmaceuticals in Nuclear Medicine market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

As per the presented market report, the global Radiopharmaceuticals in Nuclear Medicine market is projected to attain a CAGR growth of ~XX% during the assessment period and surpass a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Radiopharmaceuticals in Nuclear Medicine market hinges its hope on a range of factors including, emphasis on innovation by market players, surge in the investments pertaining to R&D activities, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2630376&source=atm

Competition Landscape

The report provides critical insights related to the business operations of prominent companies operating in the Radiopharmaceuticals in Nuclear Medicine market. The revenue generated, market presence of different companies, product range, and the financials of each company is included in the report.

Regional Landscape

The regional landscape section of the report provides resourceful insights related to the scenario of the Radiopharmaceuticals in Nuclear Medicine market in the key regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential of the Radiopharmaceuticals in Nuclear Medicine market in each region.

End-User Analysis

The report provides a detailed analysis of the various end-users of the Radiopharmaceuticals in Nuclear Medicine along with the market share, size, and revenue generated by each end-user.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Radiopharmaceuticals in Nuclear Medicine market is segmented into Diagnostic Radiopharmaceuticals Therapy Radiopharmaceuticals Enriched Stable Isotopes

Segment by Application Diagnostic Application Therapeutic Application Research Pharmaceutical Other

Global Radiopharmaceuticals in Nuclear Medicine Market: Regional Analysis The Radiopharmaceuticals in Nuclear Medicine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Radiopharmaceuticals in Nuclear Medicine market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Radiopharmaceuticals in Nuclear Medicine Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Radiopharmaceuticals in Nuclear Medicine market include: Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE)

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2630376&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2630376&licType=S&source=atm

See the article here:
How Coronavirus Pandemic Will Impact Radiopharmaceuticals in Nuclear Medicine Market 2020 Increasing Demand, Growth Analysis and Future Outlook by...

Read the Rest...

How Coronavirus Pandemic Will Impact Cell Culture Supporting Instrument Market : Report analyzes the segments and provides the relative contribution…

§ May 23rd, 2020 § Filed under Nano Medicine Comments Off on How Coronavirus Pandemic Will Impact Cell Culture Supporting Instrument Market : Report analyzes the segments and provides the relative contribution…

The report on the Cell Culture Supporting Instrument market provides a birds eye view of the current proceeding within the Cell Culture Supporting Instrument market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Cell Culture Supporting Instrument market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Cell Culture Supporting Instrument market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Cell Culture Supporting Instrument market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Cell Culture Supporting Instrument market reports provides all data with easily digestible information to guide every businessmans future innovation and move business forward.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2633694&source=atm

The worldwide Cell Culture Supporting Instrument market is an enlarging field for top market players,

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Cell Counters Filtration Systems Centrifuges CO2 Incubators Autoclaves Microscopes Biosafety Cabinets Others

Segment by Application Biopharmaceutical/Therapeutics Stem Cell Technology Cancer Research Drug Screening & Development Tissue Engineering & Regenerative Medicine Others

Global Cell Culture Supporting Instrument Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Cell Culture Supporting Instrument market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Cell Culture Supporting Instrument Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (U.K.), Lonza Group AG (Switzerland), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), Eppendorf AG (Germany), Hi-Media Laboratories (India), Sartorius AG (Germany), Promocell GmbH (Germany), etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2633694&source=atm

This Cell Culture Supporting Instrument report begins with a basic overview of the market. The analysis highlights the opportunity and Cell Culture Supporting Instrument industry trends that are impacted the market that is global. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Cell Culture Supporting Instrument insight regarding the things which are driving and affecting the earnings of the market. The Cell Culture Supporting Instrument report comprises sections together side landscape which clarifies actions such as venture and acquisitions and mergers.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2633694&licType=S&source=atm

Research objectives and Reason to procure this report:-

Finally, the global Cell Culture Supporting Instrument market provides a total research decision and also sector feasibility of investment in new projects will be assessed. Cell Culture Supporting Instrument industry is a source of means and guidance for organizations and individuals interested in their market earnings.

Continued here:
How Coronavirus Pandemic Will Impact Cell Culture Supporting Instrument Market : Report analyzes the segments and provides the relative contribution...

Read the Rest...

Nanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy – Chemistry World

§ May 23rd, 2020 § Filed under Nano Medicine Comments Off on Nanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy – Chemistry World

The unfolding Sars-2-CoV outbreak is laying bare the worlds need for effective antivirals. According to University of Lille chemist Sabine Szunerits, we should invest in this now, knowing that viruses will be an issue in the 21st century. With this in mind she and collaborators at the Pasteur Institute in Lille, France have, over the past few years, been developing a new approach to tackling viruses including coronaviruses that takes advantage of the unique properties of nanoparticles.

There are only a handful of approved antiviral treatments and these are only effective against a few specific viruses. This means that when new viral diseases like Covid-19 emerge doctors are left trying to repurpose existing antivirals in the hope that they will have an effect on the new disease.

Viruses are not technically alive, they are packages of RNA or DNA that can only replicate by hijacking its hosts genetic machinery. Antivirals do not destroy these packages, they are small molecules designed to block viral replication, thereby reducing symptoms and infectivity while the immune system deals with them. Unfortunately, because viruses rely on the hosts DNA replication machinery finding drugs that only target and bind specific virus proteins and not those of the host cell is a challenge. This lack of specificity means large doses of antivirals are often needed to achieve the desired effect, which in turn increases toxicity.

The field of nanomedicine, however, has been exploring how nanoparticles can overcome some of these problems. The promise of nanoparticle antivirals comes from their multivalency the number of interactions occurring as molecules bind together. The nanoparticle of choice for Szunerits are carbon quantum dots (CQDs) which are spherical, have a high surface-to-volume ratio and are smaller in size than viruses creating conditions where multivalent interactions can play a role. The surface of the CQDs can also be coated with molecules that bind the proteins viruses use to enter cells. The spherical shape and smaller size of the CQD mean these molecules can form extremely tight multivalent bonds with proteins all over the viruss surface, blocking it from attaching to and infecting a host cell. Szunerits and team started this work in 2018, testing the ability of CQDs with boronic acid groups to reduce the infectivity of a mild strain of human coronaviruses in cell lines.They achieved significant reductions in viral entry relative to controls and are now working on CQDs coated with Middle East Respiratory Syndrome (MERS) specific peptides, showing that CQDs should be able to be adapted to specific viral threats.

Cameron Alexander at the University of Nottingham, who works with nanoparticle-based RNA vaccines sees the potential adaptability of this type approach. Once youve got a nanoparticle with the right spacing and chemical functionalities to match one virus, its not inconceivable to think how you could plug and play different groups on that surface to find another virus.

Igor Medintz, a senior scientist with the US Naval Research Laboratory in Washington DC, agrees that the plug and play nature of this approach is promising because, as long as a molecule is biocompatible, there are few limitations to the options available. Theres a huge library of non-natural amino acids that can be accessed as well you can synthesise peptides with just about any chemical or functional group possible and those could give them very high binding affinity beyond the naturally occurring ones, he says.

Another drawback of current antivirals is that they are often insoluble making administering them more difficult. Often drugs on the market are rather hydrophobic and the pharma industry always likes delivering drugs orally, says Szunerits. Nanoparticles like CQDs are hydrophilic, however, allowing them to circulate better. Due to their size, they are also easier to deliver as a fine spray, which for infections that affect the lungs, such as coronaviruses, would be more effective.

Right now, Szunerits and the team are experimenting with liposome packages to deliver CQDs, as well as assessing the big question of how the body will handle them once theyve serve their function. Early studies by her group have shown that CQDs injected into mice are passed in urine, which along with in vitro toxicity studies provide hopeful signs that the body can tolerate them.

As with any new treatment moving from the lab to clinical trials and then scaling-up production is a long road. According to Alexander, making these types of particles is easy enough but ensuring uniformity in large batches required for a therapeutic becomes problematic. When youre making some of these systems, you need to check that the size is correct, the functionality is correct and the more functionality you put in it, the more complicated they are to characterise, he says. The more complicated to characterise, the harder it is to get regulatory approval, and the harder it is to manufacture.

Visit link:
Nanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy - Chemistry World

Read the Rest...

Assessing the Fallout From the Coronavirus Pandemic Topical Pain Management Therapeutics in Sports Medicine Market Highlighting Regional Revenue…

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Assessing the Fallout From the Coronavirus Pandemic Topical Pain Management Therapeutics in Sports Medicine Market Highlighting Regional Revenue…

Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis

The recent report presented by MRRSE on the global Topical Pain Management Therapeutics in Sports Medicine market is an in-depth analysis of the overall prospects of the Topical Pain Management Therapeutics in Sports Medicine market in the upcoming years. The data collected from credible primary and secondary sources is accurately represented in the report backed up by relevant figures, graphs, and tables. The market study covers the impact of the COVID-19 pandemic on the growth prospects of the global Topical Pain Management Therapeutics in Sports Medicine market. The report includes a quantitative and qualitative analysis of the various aspects of the market by collecting data from the key participants in the Topical Pain Management Therapeutics in Sports Medicine market value chain.

The report reveals that the global Topical Pain Management Therapeutics in Sports Medicine market is set to grow at a CAGR of ~XX% over the forecast period (2019-2029) and surpass the value of ~US$XX by the end of 2029. The presented study also includes a thorough analysis of the micro and macroeconomic factors, regulatory framework, and current trends that are expected to influence the growth of the Topical Pain Management Therapeutics in Sports Medicine market during the assessment period.

Request Sample Report @https://www.mrrse.com/sample/14010?source=atm

Vital Information Enclosed in the Topical Pain Management Therapeutics in Sports Medicine Market Report:

Important Queries Addressed in the Report

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/14010?source=atm

Topical Pain Management Therapeutics in Sports Medicine Market Segmentation

The market study put forward by MRRSE segments the global Topical Pain Management Therapeutics in Sports Medicine market to offer a microscopic understanding of the various aspects of the Topical Pain Management Therapeutics in Sports Medicine market. The Topical Pain Management Therapeutics in Sports Medicine market is segmented on the basis of region, product type, end-user, and more.

The study offers a Y-o-Y growth projection of each market segment and sub-segment over the stipulated timeframe of the study.

companies profiled in the report include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.), GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, Johnson & Johnson Services, Inc., and Topical BioMedics, Inc.

The global topical pain management therapeutics in sports medicine market has been segmented as follows:

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Product

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Therapeutic Class

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Geography

Buy This Report @ https://www.mrrse.com/checkout/14010?source=atm

Why Buy from MRRSE?

See the original post:
Assessing the Fallout From the Coronavirus Pandemic Topical Pain Management Therapeutics in Sports Medicine Market Highlighting Regional Revenue...

Read the Rest...

Global General Medicine Education Publishing Market 2020 | What Is The Estimated Market Size In The Upcoming Years? – Cole of Duty

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Global General Medicine Education Publishing Market 2020 | What Is The Estimated Market Size In The Upcoming Years? – Cole of Duty

Global General Medicine Education Publishing market report studies the market situation and outlook represents the global General Medicine Education Publishing market size (value and volume) and Share by companies, type, application, and region. The widespread Global General Medicine Education Publishing trends and opportunities are also taken into consideration in General Medicine Education Publishing industry study General Medicine Education Publishing Market report focus on the following section is to analyze the General Medicine Education Publishing industry by acceptance among various segments; the primary product types covered under the scope of the report.

MANUFACTURERScovered in this General Medicine Education Publishing market report:

Remedica Springer Nature Medical Education RELX BMJ Publishing Group Ltd Bilingual Publishing Co Cambridge Scholars Publishing Allen Press, Inc. Springer Publishing Company WCHMedia Group, Inc Thieme Medical Publishers, Inc iMedPub LTD Nova Science Publishers Horizon Research Publishing Data Trace Publishing Company

GetFREESample Report @ https://www.reportspedia.com/report/technology-and-media/global-general-medicine-education-publishing-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34155 #request_sample

This General Medicine Education Publishing market report is a complete analysis of the General Medicine Education Publishing market based on primary and secondary in-depth analysis. The scope of the General Medicine Education Publishing market report includes global and regional sales, product consumption in terms of volume, and value. The global General Medicine Education Publishing market report provides an estimate of revenue, CAGR, and aggregate revenue. The collected knowledge about General Medicine Education Publishing global business is represented in the figures, tables, pie charts, and graphs.

On the basis of product eachTYPESprimarily split into:

Electronic & Online Publishing Print Publishing

On the basis of product eachAPPLICATIONSprimarily split into:

Individual Enterprises School Hospital

Market Primarily Focusing On General Medicine Education Publishing Market:

Ask for Discount @ https://www.reportspedia.com/discount_inquiry/discount/34155

Global General Medicine Education Publishing Market: Drivers and Restrains

The research report has incorporated the analysisof variousfactors that augment the markets growth. It establishes trends, restraints, and drivers that transmute the market in either a positive or negative manner. This section also provides the scopeof varioussegments and applicationswhich willpotentially influence the marketin thefuture. The detailed informationrelieson current trends and historic milestones. This section also provides an analysis ofthe quantityof sales aboutthe worldwide General Medicine Education Publishing market and also about each type from 2015 to 2024. This section mentionsthe quantityof sales by region from 2015 to 2024. Pricing analysis is includedwithin thereportconsistent witheach type from the year 2015 to 2024, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2024.

A thorough evaluation of the restrains includedwithin thereport portrays the contrast to driversand providesroom for strategic planning. Factors that overshadow the market growth are pivotal asthey willbe understoodto plandifferent bends for getting hold of the lucrative opportunities that are presentin theever-growing General Medicine Education Publishing market. Additionally, insights into market experts opinionsaretakento knowthe market better.

Global General Medicine Education Publishing Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2024. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2024. Understanding the segments helps in identifying the importance of different factors that aid the General Medicine Education Publishing market growth.

Global General Medicine Education Publishing Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The General Medicine Education Publishing report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2024. These analyses will help the readerto knowthe potential worth of investmentduring aparticular region.

Global Market: Competitive Landscape

This section of the report finds various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players arethat specialize incombat competitionwithin themarket.The greatreport providesa bigmicroscopiccheck outthe General Medicine Education Publishing market. The reader can categorize the footprints of the manufacturers by knowing aboutthe worldwiderevenue of manufacturers,the worldwideprice of manufacturers, and sales by producers during the forecast period of 2015 to 2019.

View Report TOC In detail @ https://www.reportspedia.com/report/technology-and-media/global-general-medicine-education-publishing-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34155 #table_of_contents

See the original post here:
Global General Medicine Education Publishing Market 2020 | What Is The Estimated Market Size In The Upcoming Years? - Cole of Duty

Read the Rest...

Assessing the Fallout From the Coronavirus Pandemic China Osteoporosis Market Latest Research Report Analysis 2019-2026 – Cole of Duty

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Assessing the Fallout From the Coronavirus Pandemic China Osteoporosis Market Latest Research Report Analysis 2019-2026 – Cole of Duty

Global China Osteoporosis Market Analysis

The recent report presented by MRRSE on the global China Osteoporosis market is an in-depth analysis of the overall prospects of the China Osteoporosis market in the upcoming years. The data collected from credible primary and secondary sources is accurately represented in the report backed up by relevant figures, graphs, and tables. The market study covers the impact of the COVID-19 pandemic on the growth prospects of the global China Osteoporosis market. The report includes a quantitative and qualitative analysis of the various aspects of the market by collecting data from the key participants in the China Osteoporosis market value chain.

The report reveals that the global China Osteoporosis market is set to grow at a CAGR of ~XX% over the forecast period (2019-2029) and surpass the value of ~US$XX by the end of 2029. The presented study also includes a thorough analysis of the micro and macroeconomic factors, regulatory framework, and current trends that are expected to influence the growth of the China Osteoporosis market during the assessment period.

Request Sample Report @https://www.mrrse.com/sample/2503?source=atm

Vital Information Enclosed in the China Osteoporosis Market Report:

Important Queries Addressed in the Report

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/2503?source=atm

China Osteoporosis Market Segmentation

The market study put forward by MRRSE segments the global China Osteoporosis market to offer a microscopic understanding of the various aspects of the China Osteoporosis market. The China Osteoporosis market is segmented on the basis of region, product type, end-user, and more.

The study offers a Y-o-Y growth projection of each market segment and sub-segment over the stipulated timeframe of the study.

Companies mentioned in the research report

Some of the major domestic and international players operating in the China osteoporosis market are Merck Pharmaceutical (HK) Limited, Jiangsu Hengrui Medicine Co., Ltd., Qingdao Chiatai Haier Pharmaceutical Co., Ltd., Novartis International AG, Eli Lilly and Company, and Tongjitang Chinese Medicines Company.

By focusing on cost-effective drugs with an easy dosage pattern, players in the China osteoporosis market will be able to gain a competitive edge. The dosage schedule of traditional osteoporosis drugs is rather strict, making it difficult for patients to comply with. R&D activities aimed towards developing easy-dosage osteoporosis drugs will allow manufacturers to address the unmet medical needs of patients across China.

Segmentation based on drug class

This report gives you access to decisive data such as:

Key highlights of this report

Buy This Report @ https://www.mrrse.com/checkout/2503?source=atm

Why Buy from MRRSE?

See more here:
Assessing the Fallout From the Coronavirus Pandemic China Osteoporosis Market Latest Research Report Analysis 2019-2026 - Cole of Duty

Read the Rest...

Global Phage Therapy Market Industry Research Report, Growth Trends and Competitive Analysis 2020-2024 – Cole of Duty

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Global Phage Therapy Market Industry Research Report, Growth Trends and Competitive Analysis 2020-2024 – Cole of Duty

Global Phage Therapy market report studies the market situation and outlook represents the global Phage Therapy market size (value and volume) and Share by companies, type, application, and region. The widespread Global Phage Therapy trends and opportunities are also taken into consideration in Phage Therapy industry study Phage Therapy Market report focus on the following section is to analyze the Phage Therapy industry by acceptance among various segments; the primary product types covered under the scope of the report.

MANUFACTURERScovered in this Phage Therapy market report:

Phage International Adaptive Phage Therapeutics AmpliPhi Biosciences C3J Therapeutics Enbiotix InnoPhage iNtODEWorld Intralytix Locus Biosciences Phagomed Pherecydes Pharma TechnoPhage Eligo Bioscience Phagelux

GetFREESample Report @ https://www.reportspedia.com/report/life-sciences/global-phage-therapy-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34250 #request_sample

This Phage Therapy market report is a complete analysis of the Phage Therapy market based on primary and secondary in-depth analysis. The scope of the Phage Therapy market report includes global and regional sales, product consumption in terms of volume, and value. The global Phage Therapy market report provides an estimate of revenue, CAGR, and aggregate revenue. The collected knowledge about Phage Therapy global business is represented in the figures, tables, pie charts, and graphs.

On the basis of product eachTYPESprimarily split into:

Oral External Application Surgical Treatment

On the basis of product eachAPPLICATIONSprimarily split into:

Human Medicine Veterinary Science Agriculture

Market Primarily Focusing On Phage Therapy Market:

Ask for Discount @ https://www.reportspedia.com/discount_inquiry/discount/34250

Global Phage Therapy Market: Drivers and Restrains

The research report has incorporated the analysisof variousfactors that augment the markets growth. It establishes trends, restraints, and drivers that transmute the market in either a positive or negative manner. This section also provides the scopeof varioussegments and applicationswhich willpotentially influence the marketin thefuture. The detailed informationrelieson current trends and historic milestones. This section also provides an analysis ofthe quantityof sales aboutthe worldwide Phage Therapy market and also about each type from 2015 to 2024. This section mentionsthe quantityof sales by region from 2015 to 2024. Pricing analysis is includedwithin thereportconsistent witheach type from the year 2015 to 2024, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2024.

A thorough evaluation of the restrains includedwithin thereport portrays the contrast to driversand providesroom for strategic planning. Factors that overshadow the market growth are pivotal asthey willbe understoodto plandifferent bends for getting hold of the lucrative opportunities that are presentin theever-growing Phage Therapy market. Additionally, insights into market experts opinionsaretakento knowthe market better.

Global Phage Therapy Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2024. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2024. Understanding the segments helps in identifying the importance of different factors that aid the Phage Therapy market growth.

Global Phage Therapy Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Phage Therapy report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2024. These analyses will help the readerto knowthe potential worth of investmentduring aparticular region.

Global Market: Competitive Landscape

This section of the report finds various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players arethat specialize incombat competitionwithin themarket.The greatreport providesa bigmicroscopiccheck outthe Phage Therapy market. The reader can categorize the footprints of the manufacturers by knowing aboutthe worldwiderevenue of manufacturers,the worldwideprice of manufacturers, and sales by producers during the forecast period of 2015 to 2019.

View Report TOC In detail @ https://www.reportspedia.com/report/life-sciences/global-phage-therapy-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34250 #table_of_contents

Read more from the original source:
Global Phage Therapy Market Industry Research Report, Growth Trends and Competitive Analysis 2020-2024 - Cole of Duty

Read the Rest...

The impact of the coronavirus on the Styrenic Transparent Resins Market Solid Analyzed Segmentation, Demand, Recent Share Estimation and Growth…

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on The impact of the coronavirus on the Styrenic Transparent Resins Market Solid Analyzed Segmentation, Demand, Recent Share Estimation and Growth…

The report on the Styrenic Transparent Resins market provides a birds eye view of the current proceeding within the Styrenic Transparent Resins market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Styrenic Transparent Resins market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Styrenic Transparent Resins market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Styrenic Transparent Resins market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Styrenic Transparent Resins market reports provides all data with easily digestible information to guide every businessmans future innovation and move business forward.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2607763&source=atm

The worldwide Styrenic Transparent Resins market is an enlarging field for top market players,

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Extrusion Molding Injection Molding Other

Segment by Application Medicine Transport Consumer Goods Electronics Industrial Other

Global Styrenic Transparent Resins Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Styrenic Transparent Resins market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Styrenic Transparent Resins Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include BASF, Ineos, Eastman, Daicel Polymer, Denka, Toray, World Class Plastics, Hoehn Plastics, Chroma Color, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2607763&source=atm

This Styrenic Transparent Resins report begins with a basic overview of the market. The analysis highlights the opportunity and Styrenic Transparent Resins industry trends that are impacted the market that is global. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Styrenic Transparent Resins insight regarding the things which are driving and affecting the earnings of the market. The Styrenic Transparent Resins report comprises sections together side landscape which clarifies actions such as venture and acquisitions and mergers.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2607763&licType=S&source=atm

Research objectives and Reason to procure this report:-

Finally, the global Styrenic Transparent Resins market provides a total research decision and also sector feasibility of investment in new projects will be assessed. Styrenic Transparent Resins industry is a source of means and guidance for organizations and individuals interested in their market earnings.

Read more:
The impact of the coronavirus on the Styrenic Transparent Resins Market Solid Analyzed Segmentation, Demand, Recent Share Estimation and Growth...

Read the Rest...

Global Nanorobots Market To Witness The Highest Growth Globally In Coming Years 2020-2024 – Cole of Duty

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Global Nanorobots Market To Witness The Highest Growth Globally In Coming Years 2020-2024 – Cole of Duty

Global Nanorobots market report studies the market situation and outlook represents the global Nanorobots market size (value and volume) and Share by companies, type, application, and region. The widespread Global Nanorobots trends and opportunities are also taken into consideration in Nanorobots industry study Nanorobots Market report focus on the following section is to analyze the Nanorobots industry by acceptance among various segments; the primary product types covered under the scope of the report.

MANUFACTURERScovered in this Nanorobots market report:

Bruker Jeol Thermo Fisher Ginkgo Bioworks Oxford Instruments Ev Group Imina Technologies Toronto Nano Instrumentation Klocke Nanotechnik Kleindiek Nanotechnik Xidex Synthace Park Systems Smaract Nanonics Imaging Novascan Technologies Angstrom Advanced Hummingbird Scientific Nt-Mdt Spectrum Instruments Witec

GetFREESample Report @ https://www.reportspedia.com/report/life-sciences/global-nanorobots-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34218 #request_sample

This Nanorobots market report is a complete analysis of the Nanorobots market based on primary and secondary in-depth analysis. The scope of the Nanorobots market report includes global and regional sales, product consumption in terms of volume, and value. The global Nanorobots market report provides an estimate of revenue, CAGR, and aggregate revenue. The collected knowledge about Nanorobots global business is represented in the figures, tables, pie charts, and graphs.

On the basis of product eachTYPESprimarily split into:

Nanomanipulator Bio-Nanorobotics Magnetically Guided Bacteria-Based

On the basis of product eachAPPLICATIONSprimarily split into:

Nanomedicine Biomedical Others

Market Primarily Focusing On Nanorobots Market:

Ask for Discount @ https://www.reportspedia.com/discount_inquiry/discount/34218

Global Nanorobots Market: Drivers and Restrains

The research report has incorporated the analysisof variousfactors that augment the markets growth. It establishes trends, restraints, and drivers that transmute the market in either a positive or negative manner. This section also provides the scopeof varioussegments and applicationswhich willpotentially influence the marketin thefuture. The detailed informationrelieson current trends and historic milestones. This section also provides an analysis ofthe quantityof sales aboutthe worldwide Nanorobots market and also about each type from 2015 to 2024. This section mentionsthe quantityof sales by region from 2015 to 2024. Pricing analysis is includedwithin thereportconsistent witheach type from the year 2015 to 2024, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2024.

A thorough evaluation of the restrains includedwithin thereport portrays the contrast to driversand providesroom for strategic planning. Factors that overshadow the market growth are pivotal asthey willbe understoodto plandifferent bends for getting hold of the lucrative opportunities that are presentin theever-growing Nanorobots market. Additionally, insights into market experts opinionsaretakento knowthe market better.

Global Nanorobots Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2024. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2024. Understanding the segments helps in identifying the importance of different factors that aid the Nanorobots market growth.

Global Nanorobots Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Nanorobots report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2024. These analyses will help the readerto knowthe potential worth of investmentduring aparticular region.

Global Market: Competitive Landscape

This section of the report finds various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players arethat specialize incombat competitionwithin themarket.The greatreport providesa bigmicroscopiccheck outthe Nanorobots market. The reader can categorize the footprints of the manufacturers by knowing aboutthe worldwiderevenue of manufacturers,the worldwideprice of manufacturers, and sales by producers during the forecast period of 2015 to 2019.

View Report TOC In detail @ https://www.reportspedia.com/report/life-sciences/global-nanorobots-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/34218 #table_of_contents

Go here to read the rest:
Global Nanorobots Market To Witness The Highest Growth Globally In Coming Years 2020-2024 - Cole of Duty

Read the Rest...

Antisense & RNAi Therapeutics Market By Technology, Route of Administration, Application and Region… – Azizsalon News

§ May 20th, 2020 § Filed under Nano Medicine Comments Off on Antisense & RNAi Therapeutics Market By Technology, Route of Administration, Application and Region… – Azizsalon News

Global Antisense and RNAi Therapeutics Market was valued US$ X1.2X Bn in 2019 and is expected to reach US$ XX Bn by 2027, at CAGR of X7.XX% during forecast period of 2020 to 2027.

Global Antisense and RNAi Therapeutics Market: Overview

In past years, pharmaceutical companies were motivated about the prospective of RNA interference (RNAi). But later, financial volatility and subsequent suspensions by pharmaceutical companies have articulated that RNAi therapeutics market was fiished. Yet, advances in nano medicine helped the vast potential of RNAi therapeutics to flourish. Antisense technology offers the prospect to influence the gene expression and this is being considered as an effective treatment for various diseases. Based on this factor, great number of gene silencing drugs are in the development process.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/46233

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The global antisense and RNAi therapeutics market have gathered substantial attention in the recent years, due to its perspective to treat many sort of chronic diseases such as tuberculosis, diabetes, cancer, AIDS, as well as certain cardiovascular problems. This prospect is being cashed on by the many companies in this industry and are investing in R&D. Just to emerge as being in the clinical research division, the RNA based therapeutics are likely to be explored as a most efficient treatment choice for the disorders, which are very difficult to treat. Market is expected to grow at CAGR XX.XX% over the forecast period, as number of companies are into the development of molecules focused on antisense technology.

However, there are many challenges associated with the emerging antisense technology and RNAi. One of the noticeable issue is the drug delivery to the proposed portion. Drug delivery to the nervous tissues is one of the problems as the drug has to pass the blood-brain barrier. Major players in the industry are coming up with solutions to overcome these challenges.

The other challenge is toxic effects caused by the use of this technology. Determining the right dosage and path for drug delivery of an antisense molecule is one of the most crucial process to ensure the safe administration. While overcoming this as much as possible and implementing it, companies have encountered multiple rejections from the regulatory bodies. For instance, FDA has refused, an antisense molecule to treat familial chylomicronemia syndrome by the renowned U.S. organization Akceas Waylivra. Such events would push companies to develop better paths, efficient delivery solutions, and effective compositions.

Global Antisense and RNAi Therapeutics Market: Growth Factors

In RNAi therapeutics, more influential product focus vs. platform technologies and virtual drug expansion models that enable several companies to minimize the R&D costs, are expected to attract investors and supplement in the growth of the market. Instead, major issues in drug delivery as well as high failure rates are some of the biggest barriers for companies working in this particular field. Despite the limitations, the players in the pharmaceutical sector are interested and focused for the commercialization of these therapies, hence antisense and RNAi therapeutics market have chances to grow substantially with CAGR of XX.XX% and expected to reach US$ XX.XX Mn by the end of the forecast period.

Global Antisense and RNAi Therapeutics Market: Regional Analysis

North America has experienced to be the most lucrative market in the recent times and has contributed a substantial share in the Global Antisense and RNAi Therapeutics Market. Multiple clinical trials have shown favorable results and are even progressing through the development stages. Supposing such trials expected to show positive results, the North American market can be expected to witness the exponential growth during forecast period. Furthermore in the U.S. several biotechnology companies have made considerably high investments for RNAi therapeutic development and number of RNAi therapeutics are in final stage of development phases. In North America, clinical laboratories are likely to contribute significant revenue generation via platform and product licensing. Supportive government regulation and provision to increase the number of clinical trials therein encourages the method of initiation for exploring antisense therapeutics. The forthcoming commercialization of several players are under R&D will help to boost the global antisense and RNAi therapeutics market in North America in the forecast period.

The increasing government expenditure toward R&D, as well as different forms of siRNA delivery methods, is a strong side propelling the growth of the global antisense and RNAi therapeutics market in Asia Pacific region. Still this region is experiencing the moderate growth rate with CAGR of XX.XX% during 2014-2018, but post commercialization of these therapies, prospects, and forthcoming opportunities in the Asia Pacific are likely to be more profitable, presenting a maximum development rate with the consistently growing CAGR of XX.XX% in the forecast period from 2020 to 2027.

Antisense & RNAi Therapeutics Market Insights and developments

In the recent years there are many discoveries in the field of technologies with regards to Global Antisense & RNAi Therapeutics Market, which in turn will help the industry to grow. Big pharmaceutical developers have entered into collaboration agreements or outsourcing deals with a several of smaller firms & new entrants in an effort to take advantage of on the expected growth in revenue that this market can generate over the forecast period. For instance, Agreement between AstraZenecas and Ionis pharmaceuticals is one of the big deals that are hugely investing & doing R&D into antisense technology.

Since the discovery of RNAi in, there are various ways of treatment of multiple diseases using RNAi, still, the market has picked up very little over the past decade due to the complexities in delivery methodologies associated to RNAi. But due to initiatives by key players and ongoing R&D have shown the chances of better growth.

Rising need for the cure and prevention of diseases like cancer, AIDS and several diseases caused by mutating viruses is anticipated to impact the usage rate of oligonucleotide products. This field is rapidly expanding owing to the increasing number of clinical trials for the oligonucleotide drugs. For instance, Ionis Pharmaceuticals has 2 approved molecules in the European Union and 1 in U.S. along with 4 molecules in pipeline.

Many key players are putting efforts in developing novel delivery systems like nanocarriers, to encourage the in-vivo delivery of the oligonucleotides. To develop the bioavailability, carrying capability of siRNA payload and they deliver high interface with the target cells are the key functions of Nanocarriers, for which they are recognized mostly. The development of newer nanotechnology-oriented methods has offered high potential to the market to grow during the forecast period. Nanocarriers can reduce the toxicity of these oligonucleotides. There is huge need for the latest and harmless delivery systems for cancer and other viral diseases, which is expected to suppliment the market growth. Significant pipeline for cancer therapies by organizations and institutes such as, Enzon Pharmaceuticals (Santaris Pharma), OncoGenex, University of Texas, Astrazeneca (Ionis Pharmaceuticals), Isarna Therapeutics and INSYS Therapeutics, Inc. have huge contribution in driving the market.

Detailed analysis of competition, new entrants, strategic alliances, mergers and acquisition in the Global Antisense & RNAi Therapeutics Market is covered in the report. The report covers the market leaders and followers in the industry with the market dynamics by region. It will also help to understand the position of each player in the market by region, by segment. Global Antisense & RNAi Therapeutics Market Company Profiles

The players operating in the Global Antisense & RNAi Therapeutics Market, analyzed in the report are:

GSK, Sanofi-Genzyme, Alnylam Pharmaceuticals, Marina Biosciences, Benitec Biopharma, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Akcea Therapeutics, Quark Pharmaceuticals, Gene Signal

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/46233

Global Antisense and RNAi Therapeutics Market: Segmentation

The global antisense and RNAi therapeutics market is classified into technology, application, and route of administration. In terms of technology, the global antisense and RNAi therapeutics market is bifurcated into RNA interference and antisense RNA. The segment RNA interference is further sub-divided into miRNA and siRNA. In terms of application, the global antisense and RNAi therapeutics market are categorized into cardiovascular, oncology, renal diseases, respiratory disorder, genetic disorders, a neurodegenerative disorder, infectious diseases, and others. In terms of route of administration, the global antisense and RNAi therapeutics market is sub segmented into intravenous injections, pulmonary delivery, intraperitoneal injections, intradermal Injections, topical delivery, and other delivery methods. Global Antisense and RNAi Therapeutics Market by Technology

RNA Interference o siRNA o miRNA Antisense RNA Global Antisense and RNAi Therapeutics Market by Application

Oncology Cardiovascular Diseases (CVDs) Respiratory Disorders Renal Diseases Neurodegenerative Disorders Genetic Disorders Infectious Diseases Other Global Antisense and RNAi Therapeutics Market by Route of Administration

Pulmonary Delivery Intravenous Injections Intra-dermal Injections Intraperitoneal Injections Topical Delivery Other Delivery Methods

MAJOR TOC OF THE REPORT

Chapter One: Antisense & RNAi Therapeutics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Antisense & RNAi Therapeutics Market Competition, by Players

Chapter Four: Global Antisense & RNAi Therapeutics Market Size by Regions

Chapter Five: North America Antisense & RNAi Therapeutics Revenue by Countries

Chapter Six: Europe Antisense & RNAi Therapeutics Revenue by Countries

Chapter Seven: Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries

Chapter Eight: South America Antisense & RNAi Therapeutics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Antisense & RNAi Therapeutics by Countries

Chapter Ten: Global Antisense & RNAi Therapeutics Market Segment by Type

Chapter Eleven: Global Antisense & RNAi Therapeutics Market Segment by Application

Chapter Twelve: Global Antisense & RNAi Therapeutics Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Antisense & RNAi Therapeutics Market Report at:https://www.maximizemarketresearch.com/market-report/global-antisense-rnai-therapeutics-market/46233/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Read more:
Antisense & RNAi Therapeutics Market By Technology, Route of Administration, Application and Region... - Azizsalon News

Read the Rest...

The rush to get a football show back on the diligently disinfected road – The Guardian

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on The rush to get a football show back on the diligently disinfected road – The Guardian

Liverpool fan gets a view of Liverpool training on Tuesday. Photograph: Peter Powell/EPA

Renowned for his no-nonsense, highly aggressive and combative style, it is odd that Troy Deeney has voiced his fears over a microscopic lump of practically nothing measuring just 120 nanometers in diameter, surrounded by a glycoprotein membrane and topped off with distinctive protein spikes. Indeed, had Liverpool known of the Watford captains reluctance to risk sharing a pitch with such a virus, they might have picked it ahead of Dejan Lovren back in early March and maintained their hopes of emulating Arsenals Premier League-winning Invincibles intact.

Rarely backwards in coming forwards, whether its to attack a cross into the box or the latest contentious issue of the day, Deeney announced on Monday that while the majority of Premier League players were preparing to return to their training grounds for phase one of TV Money Scramble, he would not be joining them because he hasnt been given enough assurances that doing so would be safe. Were due back in this week, Ive said Im not going in, he told renowned football interrogators Eddie Hearn and Tony Bellew. It only takes one person to get infected within the group and I dont want to be bringing that home. My son is only five months old, he had breathing difficulties, so I dont want to come home to put him in more danger.

Deeneys decision has met with mixed verdicts in the all important court of public opinion. Some on assorted social media abominations fully support his decision not to risk the health of his infant child, while apparently more qualified medical experts have insisted that because Deeney earns a lot of money, it is beholden upon him to do whatever they say. Meanwhile back in real life, actual medical experts, specifically a majority of the collective body who work at various Premier League and Football League clubs, are similarly unenthused by the stampede back to the training grounds, saying they have not been sufficiently consulted in the rush to get a football show that not many people seem particularly interested in back on the diligently disinfected road.

As frontline staff who are implementing these strategies, their collective views should have been heard, said Football Medicine and Performance Association CEO, Eamonn Salmon. All of which wise chuntering leads The Fiver to suspect the football authorities must be pining for the days in which doctors were, to borrow a phrase from Cosmo Kramer, a bunch of yes-men and lackeys all towing the company line. And while the Premier League stops for no man and even remains sniffily indignant that it had to momentarily kow-tow in the face of a sweeping pandemic, it seems determined to get back up and running as soon as possible. It appears to do so with or without crucially the unanimous approval of knowledgeable medical professionals deemed unworthy of consultation, even though it is at them the Big Finger of Blame will immediately be pointed at the first sign of anything going horribly wrong.

In the hygiene concept the guideline is to celebrate within social distancing rule. One can imagine at the height of a goal being scored that maybe, sometimes, the players get closer. The clubs are working actively with players. They speak to them every day to remind them of what needs to be done to ensure we earn the right to a second matchday and a third and to finish the season senior Bundesliga suit Robert Klein reminds teams to respect social space, goal celebrations or not, after some flagrant disregarding at the weekend.

Its your boy, David Squires, on the Bundesliga! And you can buy it here.

To appease your Scottish reader, not a movie but a unique mention of fitba on TV (Fiver letters passim) in this wonderful clip from Succession Steve Dunn.

My nomination: Lee Mack accepting his Bafta in 2019 with a deft dig at the BBCs scheduling priorities (among a few other targets, because its the blessed Lee Mack). Start at 44s for the football part Eric Peterson.

Like yourselves I cant be ar$ed doing any proper research but Educating Rita was on the box a couple of nights ago and, at one point, Julie Walters husband was listening to the football results. I vaguely recall hearing both Port Vale and Wrexham mentioned. To make it even sadder he then went to the pub Morgan.

Re: yesterdays Still Want More? After Real Madrids famous European Cup victory at Hampden, Ferenc Puskas collared former Scotland international Jim Baxter and asked him where they could extend the evenings entertainment. Baxter eventually found a party in Drumchapel on the outskirts of Glasgow, explaining afterwards that the housing department should have put up a plaque on the tenement saying: Ferenc Puskas of Real Madrid scored here on 18 May 1960 Paul OSullivan.

Send your letters to the.boss@theguardian.com. And you can always tweet The Fiver via @guardian_sport. Todays winner of our prizeless letter othe day is Steve Dunn.

Heres the latest Football Weekly podcast and our new Forgotten Stories of Football audio read too.

Sorry your browser does not support audio - but you can download here and listen https://audio.guim.co.uk/2020/05/12-56802-gnl.fsof.200513.jf.Fascism.mp3

The Premier League has revealed that six players or staff tested positive for coronavirus in its first round of testing. The league carried out 748 tests and has said the positive tests were spread across three clubs.

Red-hot admin updates wait for no pandemic: Manchester Citys appeal against their two-year ban from European competitions will be heard by the Court of Arbitration for Sport between 8-10 June.

Hull City are feeling fresh and funky following reports that theyve become the first Championship club to outline their opposition to restarting the season. We are disappointed that a letter which was intended to remain private between the EFL and other Championship clubs has been leaked, fumed a statement.

The players, coaching staff and management at Swiss champions Young Boys have agreed to temporary wage cuts to help the club balance the books and pay its 140 support staff during the shutdown. It is natural for the team to show solidarity with the club and the employees in these times, said captain Fabian Lustenberger. We also want to show that we can only overcome the crisis together.

Manchester United have urged supporters to stay away from behind-closed-doors games if the season restarts. By supporting from home and following government guidance, you will be playing your part to keep your friends, your family and all United fans safe, said the club.

And Queens Celtic manager Neil Lennon doesnt think he needs to make any new signings before the team embark on chasing their 10th consecutive Scottish title. I am not sure we need to do a lot of rebuilding at all, if at all, he cheered.

Barney Ronay on the Premier League riding shotgun into an unknown future.

Twenty years on from Deportivos sole La Liga title triumph, Donato gets his chat on with Sid Lowe about his decisive goal.

Thomas Mller is the perfect ghost player for the ghost games currently being put before us, writes Jonathan Liew.

Gary Naylors favourite game: when Everton roared back against Wimbledon in 1994 to seal Premier League safety at the last.

Oh, and if its your thing you can follow Big Website on Big Social FaceSpace. And INSTACHAT, TOO!

Read the rest here:
The rush to get a football show back on the diligently disinfected road - The Guardian

Read the Rest...

Global Medical Second Opinion Market 2020 | What Is The Estimated Market Size In The Upcoming Years? – Cole of Duty

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Global Medical Second Opinion Market 2020 | What Is The Estimated Market Size In The Upcoming Years? – Cole of Duty

Global Medical Second Opinion market report studies the market situation and outlook represents the global Medical Second Opinion market size (value and volume) and Share by companies, type, application, and region. The widespread Global Medical Second Opinion trends and opportunities are also taken into consideration in Medical Second Opinion industry study Medical Second Opinion Market report focus on the following section is to analyze the Medical Second Opinion industry by acceptance among various segments; the primary product types covered under the scope of the report.

MANUFACTURERScovered in this Medical Second Opinion market report:

HCA Hospitals AXA PPP Healthcare Royal London Group Helsana Group Cleveland Clinic Amradnet Best Doctors Inc Inova Care Toranomon Hospital Keio University Hospital Johns Hopkins Medicine Penn Medicine Oncology International Pvt. Ltd. GrandOpinion London Pain Clinic Mondial Assistance Medisense Medo Asia Sdn. Bhd.

GetFREESample Report @ https://www.reportspedia.com/report/life-sciences/global-medical-second-opinion-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/33753 #request_sample

This Medical Second Opinion market report is a complete analysis of the Medical Second Opinion market based on primary and secondary in-depth analysis. The scope of the Medical Second Opinion market report includes global and regional sales, product consumption in terms of volume, and value. The global Medical Second Opinion market report provides an estimate of revenue, CAGR, and aggregate revenue. The collected knowledge about Medical Second Opinion global business is represented in the figures, tables, pie charts, and graphs.

On the basis of product eachTYPESprimarily split into:

Hospitals Medical Second Opinion Providing Companies Health Insurance Companies

On the basis of product eachAPPLICATIONSprimarily split into:

#VALUE!

Market Primarily Focusing On Medical Second Opinion Market:

Ask for Discount @ https://www.reportspedia.com/discount_inquiry/discount/33753

Global Medical Second Opinion Market: Drivers and Restrains

The research report has incorporated the analysisof variousfactors that augment the markets growth. It establishes trends, restraints, and drivers that transmute the market in either a positive or negative manner. This section also provides the scopeof varioussegments and applicationswhich willpotentially influence the marketin thefuture. The detailed informationrelieson current trends and historic milestones. This section also provides an analysis ofthe quantityof sales aboutthe worldwide Medical Second Opinion market and also about each type from 2015 to 2024. This section mentionsthe quantityof sales by region from 2015 to 2024. Pricing analysis is includedwithin thereportconsistent witheach type from the year 2015 to 2024, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2024.

A thorough evaluation of the restrains includedwithin thereport portrays the contrast to driversand providesroom for strategic planning. Factors that overshadow the market growth are pivotal asthey willbe understoodto plandifferent bends for getting hold of the lucrative opportunities that are presentin theever-growing Medical Second Opinion market. Additionally, insights into market experts opinionsaretakento knowthe market better.

Global Medical Second Opinion Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2024. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2024. Understanding the segments helps in identifying the importance of different factors that aid the Medical Second Opinion market growth.

Global Medical Second Opinion Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Medical Second Opinion report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2024. These analyses will help the readerto knowthe potential worth of investmentduring aparticular region.

Global Market: Competitive Landscape

This section of the report finds various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players arethat specialize incombat competitionwithin themarket.The greatreport providesa bigmicroscopiccheck outthe Medical Second Opinion market. The reader can categorize the footprints of the manufacturers by knowing aboutthe worldwiderevenue of manufacturers,the worldwideprice of manufacturers, and sales by producers during the forecast period of 2015 to 2019.

View Report TOC In detail @ https://www.reportspedia.com/report/life-sciences/global-medical-second-opinion-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/33753 #table_of_contents

Originally posted here:
Global Medical Second Opinion Market 2020 | What Is The Estimated Market Size In The Upcoming Years? - Cole of Duty

Read the Rest...

Why Pharma Manufacturers Are Riding the ERP Wave – CXOToday.com

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Why Pharma Manufacturers Are Riding the ERP Wave – CXOToday.com

By: Jan Biezepo

Growing competition, consumer expectations, and complex external environment has made businesses across industries look for ways to differentiate themselves. Therefore, streamlined workflow, centralized management, agile decision making, and data backed analytics have become need of the hour in every industry. To respond to this changing scenario, Enterprise Resource Planning (ERP) software is a natural choice for businesses. Every industry has its unique reasons to implement a suitable ERP software system. The same is true for the pharmaceutical industry.

The last several years have been extremely dynamic for the pharmaceutical industry. Competitive pressure, price wars, stringent production regulations, and the continuous ask to churn innovation has kept the players on their toes.The pharma companies are now facing an informed customer and a vigilant regulator.Consumers are looking for healthcare products with the highest quality and the best price. The pharma manufacturers and distributorsmust respond to this need by reducing cost, streamlined operations and maximizing efficiency.Hence, there is no choice but to ensure the highest quality standards across all processes, along with faster production lines, and precise regulatory compliance.

ERP software empowers pharma companies to integrate, consolidate and automate all the key functions.Therefore, businesses can keep a track of their sensitive operations across functions such as quality control, intellectual property, compliance, expiry management, formulation, costing and finance, and so on. The ability to provide a microscopic or birds eye view of the organization wide processes, as per the need,is the key reason for pharma manufacturing industryto increasingly adopt an ERP system. Here is how an ERP system enables seamlessly synchs several operations and connects the dots across a pharma business:

Regulatory compliance

An ERP system can manage comprehensive compliance amid continuous changes in the regulatory landscape. compliance managers can set triggers, validate internal protocols, and initiate checks and balances using an ERP. Since pharma ERP is specialized software designed for the industry, it integrates formulation management with regulatory mandate to provide full compliance.

Similarly, it helps in document management that forms the core of statutory vigilance and audits. Recording all historical data of every process and related documentation is mandatory for audit checks and future analysis.For instance, there could be an important piece of information from R&D centers that can be stored at a single point and accessed remotely using an ERP system.

Inventory and material management

Pharma ERP offers modules that allow inventory managers to control pilferage and monitor inventory levels. All material requirements for production are maintained in real time. There is also an option to create triggers for procurement and replenishment, monitors material usage, reconcile inventory levels and generate inventory status dashboard at a predefined frequency.

Distribution Management

The batch and lot tracking play a very important role in the pharma industry. Think of a time when the entire batch of a medicine is required to be replaced amid a regulatory crisis. ERP module provides a dedicated module to monitor batches at every stage. Be it requisition stage, in-progress quality check (IPQC), or sales at retail store, manufacturers never lose the sight of what they produce. Such a feature could be life savior at times.

Sales and marketing management

An ERP system can help with sales order processing and contract management instantly by using pre-defined templates. It can also store and manage customer records and history; create competitive price quote basis past data, map this information with respect to a sales order, and create automated marketing workflows. This means that driving promotional campaigns can be done from a single window.

Recipe Management

This is perhaps the most important aspect where ERP system helps pharmaceutical manufacturers. Extreme competition in the industry means that the players often engage in a price war. The formulation of ingredients is very critical to control the price and effectiveness of the drug. An ERP system can store critical drug recipes with necessary level of safety and security.

The application of ERP system for pharma industry is not limited to the above. With the advent of artificial intelligence and machine learning, the system can learn on the go and become more useful for anorganization. However, every pharma manufacture, while implementing the ERP should evaluate the suitability, flexibility and level of customization possible to accommodate the future changes in the external environment.

(The author is Managing Director-South Asia, QAD and the views expressed in this article are his own)

More:
Why Pharma Manufacturers Are Riding the ERP Wave - CXOToday.com

Read the Rest...

Global trade impact of the Coronavirus Medical Scavenging System Expansion to be Persistent During 2019-2042 – Jewish Life News

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Global trade impact of the Coronavirus Medical Scavenging System Expansion to be Persistent During 2019-2042 – Jewish Life News

In 2029, the Medical Scavenging System market is spectated to surpass ~US$ xx Mn/Bn with a CAGR of xx% over the forecast period. The Medical Scavenging System market clicked a value of ~US$ xx Mn/Bn in 2018. Region is expected to account for a significant market share, where the Medical Scavenging System market size is projected to inflate with a CAGR of xx% during the forecast period.

In the Medical Scavenging System market research study, 2018 is considered as the base year, and 2019-2029 is considered as the forecast period to predict the market size. Important regions emphasized in the report include region 1 (country 1, country2), region 2 (country 1, country2), and region 3 (country 1, country2).

The report on the Medical Scavenging System market provides a birds eye view of the current proceeding within the Medical Scavenging System market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Medical Scavenging System market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2639224&source=atm

Global Medical Scavenging System market report on the basis of market players

The report examines each Medical Scavenging System market player according to its market share, production footprint, and growth rate. SWOT analysis of the players (strengths, weaknesses, opportunities and threats) has been covered in this report. Further, the Medical Scavenging System market study depicts the recent launches, agreements, R&D projects, and business strategies of the market players including

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type Active Vacuum Systems Passive Vacuum Systems Centralized

Segment by Application Anesthetic Gas Aerosolized Medicine Other Gases

Global Medical Scavenging System Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Medical Scavenging System market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Medical Scavenging System Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2639224&source=atm

The Medical Scavenging System market report answers the following queries:

The Medical Scavenging System market report provides the below-mentioned information:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2639224&licType=S&source=atm

Research Methodology of Medical Scavenging System Market Report

The global Medical Scavenging System market study covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). Both top-down and bottom-up approaches have been used to calculate and authenticate the market size of the Medical Scavenging System market, and predict the scenario of various sub-markets in the overall market. Primary and secondary research has been thoroughly performed to analyze the prominent players and their market share in the Medical Scavenging System market. Further, all the numbers, segmentation, and shares have been gathered using authentic primary and secondary sources.

Visit link:
Global trade impact of the Coronavirus Medical Scavenging System Expansion to be Persistent During 2019-2042 - Jewish Life News

Read the Rest...

Potential Impact of COVID-19 on Sports Medicine Devices to Remain Lucrative During 2019-2029 – News Distinct

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Potential Impact of COVID-19 on Sports Medicine Devices to Remain Lucrative During 2019-2029 – News Distinct

Analysis of the Global Sports Medicine Devices Market

The recent market study suggests that the global Sports Medicine Devices market is expected to grow at a CAGR of ~XX% between 2019 and 2029 and reach a value of ~US$XX by the end of 2029.

The study offers a microscopic view of the various segments and sub-segments of the Sports Medicine Devices market and accurately represents the data using informative tables, graphs, and figures. The objective of the report is to assist readers to make informed business decisions and improve their position in the global Sports Medicine Devices market landscape post the COVID-19 pandemic.

Request Sample Report @https://www.mrrse.com/sample/3189?source=atm

Vital data enclosed in the report:

Segmentation Analysis of the Sports Medicine Devices Market

The Sports Medicine Devices market study offers a detailed understanding of the consumption, demand, and pricing structure of each product.

The Sports Medicine Devices market report evaluates how the Sports Medicine Devices is being utilized by various end-users.

By Region

The report offers valuable insights related to the growth prospects of the Sports Medicine Devices market in different regions including:

Some of the major players in sports medicine devices profiled in this report include Arthrex, Arthrocare, Biomet, Inc., Stryker Corporation, Wright Medical Technology, Inc., DJO Global, OttoBock Healthcare GmbH, Ossur hf and Zimmer Holdings, Inc. Each of these market players are profiled in this report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Questions Related to the Sports Medicine Devices Market Catered to in the Report:

See more here:
Potential Impact of COVID-19 on Sports Medicine Devices to Remain Lucrative During 2019-2029 - News Distinct

Read the Rest...

The first 100: COVID-19 took black lives first. It didn’t have to. – Peoria Journal Star

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on The first 100: COVID-19 took black lives first. It didn’t have to. – Peoria Journal Star

In Chicago, 70 of the citys 100 first recorded victims of COVID-19 were black. Their lives were rich, and their deaths cannot be dismissed as inevitable. Immediate factors could and should have been addressed.

ProPublica Illinois is a nonprofit newsroom that investigates abuses of power.

Larry Arnold lived less than a mile from a hospital but, stepping out of his South Side apartment with a 103-degree fever, he told the Uber driver to take him to another 30 minutes away.

Charles Miles breathing was so labored when a friend called to check on him that the friend called an ambulance. Still, Miles, a retired respiratory therapist, was reluctant to leave his home.

Close family support had helped Rosa Lynn Franklin recover from a stroke several years ago, but when she was admitted to the hospital in late March, her daughter could do little more than pat her on the back and say goodbye.

All three were among the first people to die of COVID-19 in Chicago, and all three were African American. Their deaths reflect the stunning racial disparity in the initial toll of the virus. Of the citys first 100 recorded victims, 70 were black.

As the pandemic has spread, that gap has narrowed, and Latinos now make up the largest portion of any reported demographic of confirmed cases across Illinois, state data shows. But the disparity in black deaths persists. As of early May, African Americans, who make up just 30% of Chicagos population, are about half of its more than 1,000 coronavirus deaths.

It has been well established that African Americans are dying of COVID-19 at a disproportionate rate in cities across America. ProPublica sought to explore the problem by examining the first 100 recorded deaths in Chicago, a city with a rich and often troubled history on issues of race.

Using a database obtained from the Cook County Medical Examiners Office that listed the names, health and location information of all COVID-19-related deaths, reporters reached out to the families and friends of each person who died. Reporters ultimately spoke with those who knew 22 of the victims; gleaned details about the lives of many others from obituaries and social media posts; and interviewed experts, medical professionals and government officials to understand how and why those first 100 died.

The racial disparities in coronavirus deaths have largely been attributed to endemic and entrenched inequalities in Chicago decades of disinvestment in the predominantly black neighborhoods on the South and West sides that have left residents with fewer jobs, poorer health and diminished opportunities. Those forces often are portrayed as intractable and, during a pandemic, nearly impossible to fix.

Chicago Mayor Lori Lightfoot acknowledged the challenge when she spoke publicly about the disparities last month and announced a plan to address them.

Were not going to reverse this in a moment, overnight, but we have to say it for what it is and move forward decisively as a city, and thats what we will do, she said. This is about health care accessibility, life expectancy, joblessness and hunger.

While all this is true, ProPublicas reporting also revealed other patterns, factors that could and should have been addressed and which almost certainly exist in other communities experiencing similar disparities. Even though many of these victims had medical conditions that made them particularly susceptible to the virus, they didnt always get clear or appropriate guidance about seeking treatment. They lived near hospitals that they didnt trust and that werent adequately prepared to treat COVID-19 cases. And perhaps most poignantly, the social connections that gave their lives richness and meaning and that played a vital role in helping them to navigate this segregated city that can at times feel hostile to black residents made them more likely to be exposed to the virus before its deadly power became apparent.

Many of the first 100 recorded Chicago COVID-19 victims led lives threaded through with community and civic involvement, powerfully connected to their city, to friends and family. Some had led careers of service, like Patricia Frieson, a retired nurse, and Rhoda Hatch, a former teacher, and Carl Redd, a U.S. Army veteran. Their small businesses helped shape their corners of the city; Hardwell Smith, 85, arrived in Chicago as part of the Great Migration from the Jim Crow South and established gas stations and auto repair shops on the South Side. They were church deacons and musicians; doting uncles like 32-year-old Carl White and nurturing mothers like Juliet Davis, who, despite her limited means, fed the homeless who lived under a neighborhood viaduct.

Most of the first 100 lived in majority-black neighborhoods, according to an analysis of medical examiner data; hardest hit were South Shore, Auburn Gresham and Austin, where the median income for 40% or more of the residents in each community is less than $25,000.

Many were already sick, with underlying health conditions. Seventy-eight of them had hypertension and 53 had diabetes. Just 12 had one health condition, and only five people had no comorbidities. James Brooks, a 27-year-old black man, was the youngest to die.

Im not surprised because every natural disaster will peel back the day-to-day covers over society and reveal the social fault lines that decide in some ways who gets to live and who gets to die, said Dr. David Ansell, senior vice president for community health equity at Rush University Medical Center. And in the United States, those vulnerabilities are often at the intersection of race and health.

Ansell, who wrote The Death Gap: How Inequality Kills, has spent decades documenting the life expectancy gap between black and white Chicagoans, which is the largest in the country. Structural racism, concentrated poverty, economic exploitation and chronic stress cause whats known as biological weathering, Ansell said, where the body ages prematurely and results in earlier death.

Who dies first is different for each pandemic, said Dr. Howard Markel, director of the Center for the History of Medicine at the University of Michigan. The coronaviruss earliest victims, he said, were the most vulnerable.

Theyre not quite forgotten, but we dont pay close enough attention to the health and well-being of this segment of the population, he said. Then a microscopic organism comes and topples them over.

They were vulnerable, but their deaths cannot be dismissed as inevitable.

Philip Thomas, 48, started to feel sick while working a day shift at the Walmart in Evergreen Park. A diabetic, he was cautious about his health, and he reached out to a doctor, who told him to stay home and self-quarantine in case he had the coronavirus.

About a week into his bedrest, Thomas told his sister Angela McMiller that he was having a hard time standing up and was vomiting, no longer able to keep anything down. She encouraged him to go to the emergency room, but he didnt immediately go, citing the doctors advice to stay home.

Within a couple of days, he called an ambulance, which took him to Jackson Park Hospital, where he was intubated. Two days later, on March 29, he died, in the hospital where he was born.

When McMiller next saw her brother, it was at his funeral, which only 10 people could attend because of social distancing requirements. It was devastating, said McMiller. My mother fell down, my brothers cried.

McMiller is upset that her brother was told to stay home when he was sick, particularly considering the additional risks posed by his health history.

It shocked me, she said. He was diabetic.

Since the earliest days of the pandemic, the Centers for Disease Control and Preventions guidelines have emphasized staying home when symptoms are mild. Most people with COVID-19 have mild illness and can recover at home without medical care, the CDC says on its website. It recommends people call a doctor before going to get care in person, unless experiencing emergency signs like trouble breathing, blue lips or chest pain.

But experts told ProPublica that this one-size-fits-all advice does not account for the fact that African Americans are not only more likely to have preexisting conditions that increase their chances of bad outcomes, but also have a long-standing wariness of the health care system.

There is this distrust between black communities and health care systems based on this fraught history of how health care systems have exploited and abused black people, said Dr. Uch Blackstock, an emergency medicine physician in Brooklyn and the founder and CEO of Advancing Health Equity. What happens as a result of that is that patients dont want to interface with the health care system.

In addition, doctors said patients may delay seeking care out of a fear of the medical bills, lack of insurance or transportation barriers all of which underscores the need for targeted guidance. So instead of encouraging staying at home, these doctors want guidance to encourage African American patients to proactively seek care before symptoms get out of hand.

Dr. Mira Iliescu-Levine, a pulmonary critical care doctor at The Loretto Hospital on Chicagos West Side, is concerned that African American and Latino patients are waiting to come to the hospital after their symptoms become too severe.

You end up with an overwhelming clinical picture, almost like a tornado, thats very hard to stop, she said.

She said she wants patients, especially her African American patients with diabetes, obesity and other comorbidities, to seek care when they have innocent symptoms like a cough, runny nose, itchy eyes or low-grade fever.

Earlier treatment does not guarantee a better outcome, she said, but it can give the patient a fighting chance.

Reach out, she said. Dont wait.

Asked whether the CDC would consider tailoring its recommendations to reflect the underlying health conditions and barriers to care in African American communities, a spokesperson said the CDC is collecting data to monitor and track disparities among racial and ethnic groups to help inform decisions on how to effectively address observed disparities. We will continue to update our recommendations as we learn more.

The CDC spokesperson said the agency has increased engagement with organizations and other partners representing and serving racial and ethnic minority groups to identify gaps in the current response efforts, and that people should never avoid emergency rooms or wait to see a doctor if you feel your symptoms are serious.

On the first day, Willie Flake, a 72-year-old mechanic, lost his ability to taste. Then, he lost his appetite. With each new coronavirus symptom he experienced, his sister Betty and her daughter Yolanda pushed him to go to the hospital.

But Flake, who had diabetes, stayed home because he thought his symptoms were not severe enough to go to the emergency room. He soon developed a fever. By the fourth day, he had trouble breathing.

Flake took an ambulance to Rush University Medical Center on March 27, where his condition appeared to stabilize before worsening again.

They say, Dont come in until your fever is high and you cant breathe, Yolanda Flake said. Thats the part where I feel like they failed him. He waited until he couldnt breathe and it was too late.

In the early hours of April 1, his sister and niece put on masks and gloves and looked through the glass window of his hospital room. He had been like a father to Yolanda, attended every graduation, from kindergarten through college, and had recently accompanied her to buy a car for her daughter, his 23-year-old grandniece, LaSeanda.

Yolanda said she wished she could have been with him inside the room, regardless of the risks.

I wanted to touch him, she said. I wanted to talk to him before he took his last breath. I couldnt say it through the glass door.

And then, his heart stopped.

He waited at home, Yolanda said, and he was dying already.

Larry Arnold also waited, not because he was instructed to, but because he didnt trust his neighborhood hospitals.

Two Jackson Park Hospital and South Shore Hospital sit within five minutes of his home. Both are century-old nonprofit facilities that serve majority low-income and uninsured patients on the South Side. When Arnold started to feel sick in mid-March, he worried that if he called an ambulance, it would take him to one or the other. He didnt want to go to either.

What upsets me is that we dont have adequate medical facilities where we can go to and feel like well be cared for, his niece Angelyn Vanderbilt said. Im sure theyre very good people but the consensus in the community is that those hospitals are inadequate and they have been for years.

After his fever didnt subside for a few days, Arnold, who was 70 and had chronic obstructive pulmonary disease, or COPD, knew he couldnt wait any longer, his family said. He got into an Uber with a temperature of 103 and told the driver to take him to Advocate Christ Medical Center in Oak Lawn, some 30 minutes away.

On March 31, 16 days after he was admitted, the nurse put the phone to Arnolds ear one last time.

We told him to be strong and to continue to fight, Vanderbilt said.

He died about an hour later.

People who live on Chicagos South and West sides are often at a geographic disadvantage during medical crises because the hospitals that are closest to them frequently are those with fewer resources.

Illinois Gov. J.B. Pritzker acknowledged the hardships at a press briefing last month. The safety-net hospitals are challenged in our state, and the availability of health care in communities of color has been at a lower quality or lower availability than in other communities, he said.

The citys safety-net hospitals, facilities that serve a large portion of low-income and uninsured patients regardless of their ability to pay, dont have the private-insurance patient base or the cash reserves to fall back on during a pandemic that many larger hospitals have, said Larry Singer, associate professor at the Beazley Institute for Health Law and Policy at Loyola University Chicago School of Law. Some are millions of dollars in the red and housed in aging buildings. And while their mission is a valiant one, he said, they have not been able to respond to the coronavirus as quickly or with the same equipment and staffing.

Theyre trying to fight the same fight as everybody else with one arm tied behind their back, Singer said. They deserve the resources to do an even better job. Im truly impressed by what they are trying to achieve during a time of crisis.

Tim Caveney, president and CEO of South Shore Hospital, said that limited resources is one reason safety-net hospitals have struggled to earn the trust of the communities they serve. Safety net [hospitals] have gotten a bad beat because we dont have much money. Its a funding issue, he said, adding that the pandemic has aggravated South Shores financial issues. Not only have lucrative elective surgeries been postponed, but COVID-19 patients often require complex and lengthy care, which can be expensive.

Dr. Khalilah Gates, an African American pulmonary and critical care specialist at Northwestern Memorial Hospital who has family on the South Side, said she is painfully aware that some black patients may prefer to wait it out or travel to distant hospitals.

Both of those are very common phenomenons, she said. Not all community hospitals, but many of the community hospitals in those communities lack the resources that offer security to the residents in those areas.

ProPublica spoke with several families who said their loved ones either delayed care because they didnt want to go to neighborhood hospitals or ultimately wound up in those hospitals as a last resort.

Miles, the retired respiratory therapist, had worked for about 40 years at Northwestern Memorial Hospital providing breathing treatments for patients there. When he started feeling sick in mid-March, he knew what resources he might need.

A friend called him on March 22 and heard his labored breathing. He told Miles that he was calling an ambulance, but Miles resisted, in part, because he didnt want to be taken to Jackson Park, the nearest hospital.

He shouldve been in there a week before that, said his sister Roselle Jones. But he was insistent on not going.

The paramedics said that they had to take him to Jackson Park because it was the closest hospital. Miles family asked that he be transferred to another hospital, but once he tested positive for the coronavirus, a doctor told the family that Miles couldnt be moved, Jones said.

By the end of the week, Miles had been sedated and placed on a ventilator. He died on April 3.

We wanted him out of there. We wanted him somewhere he could get some good care, Jones said. The doors should be closed, and the building torn down.

Philman Williams family also said they tried in vain to get him transferred out of Jackson Park after an ambulance took him there. Williams, 70, worked as a doorman at a luxury high-rise where residents dubbed him the Mayor of Michigan Avenue for his charm and good humor. Not only was his doctor at another hospital, but the family worried about the quality of care he would receive.

A day after he was admitted, their concerns were amplified by a news story detailing reports from employees that the hospital did not have enough personal protective equipment, prompting nurses to avoid entering patient rooms.

Nurses who were sick and those afraid to come to work because they had elderly relatives at home have led to staffing shortages, said Kindra Perkins, a representative with National Nurses United, the union that represents nurses at Jackson Park. One day, an ambulance couldnt drop off a patient because there were only two nurses working in the emergency room, she said.

The nurses deserve to have the resources that they need to provide the quality care in that community, and the people in that community are just as important as the folks on the North Side of Chicago, Perkins said.

Margo Brooks-Pugh, a vice president of development at Jackson Park Hospital, did not answer specific questions, but she wrote in an email that the hospital takes patient and staff safety seriously.

Jackson Park Hospital follows all guidelines and standards as related to patient care and safety, she wrote.

Austin, on the West Side, is one of the citys largest and most chronically underserved areas. It has become a hot spot for COVID-19 cases. The Loretto Hospital, a small nonprofit that has been an anchor in the community for more than 90 years, is the primary provider in the area. Like many of the safety-net hospitals in Chicago, it has struggled financially for years.

When Asberry Stoudemire Jr., a 54-year-old diabetic, got a runny nose, then felt his blood sugar levels begin to fall, his family knew he needed to get care quickly. He also had a history of congestive heart failure, which had forced the avid stepper and musician to retire early from his job as a certified nursing assistant. The Loretto Hospital wasnt their first choice or their second. But it was the closest. Within hours of arriving at Loretto, his condition deteriorated so rapidly that he was sedated and intubated.

His daughter Miranda Stoudemire said she had trouble getting a clear sense of what was going on in the 10 days her father spent in the hospitals recently reopened 15-bed ICU. Loretto couldnt afford to keep the unit up and running before the pandemic, a fate hospital administrators said they fear could be repeated without an infusion of cash as the pandemic continues.

He was saying, I know one thing, Im not going to Loretto, she said. But he did, and she is resolute in her belief that her father would have lived longer had he been at a better resourced hospital. His family tried having him transferred but said they were told he was too critical to be moved.

I feel like he didnt even have a chance to fight, she said.

He died March 29.

Mark A. Walker, spokesman for The Loretto Hospital, said that the hospital has the capacity to care for its patients and is doing its best to communicate with families.

This hospital has gone through hard times, he said. Were doing everything we can. Were learning along with everybody else. But better resourced communities dont have to fight for the same divvy of health care resources that we do.

Although L.B. Perry was 78 and suffered from hypertension and diabetes, nothing usually kept him in bed. So when he didnt wake at 6:30 for his morning oatmeal and coffee, his family began to worry.

As he grew weaker and needed help walking to the bathroom, his family urged him to go to the hospital. After a few days, he relented and went to Holy Cross Hospital in Chicago Lawn on the South Side, but he was sent home, his daughter Vernice Perry said.

Thats why Im so upset, she said. He was in the age bracket, and he has all these health conditions, and he had some of the symptoms.

His condition worsened at home, and his daughter said she begged him to let her drive him to another hospital. Four days later, his wife called an ambulance in the early morning of March 30, and he returned to Holy Cross Hospital. He died on April 2.

Dan Regan, a spokesperson for Sinai Health System, did not answer questions about specific patients, citing privacy restrictions. He said that its hospitals, including Holy Cross, are thoroughly prepared for handling the COVID-19 pandemic, having created dedicated COVID-19 teams, using mobile triage trailers outside facilities to handle sick patients, and isolating COVID-19 patients in specialized rooms.

It is worth noting though that the challenging nature of COVID-19 is that patients can look fine at one point and be discharged home with monitoring and follow-up, only to deteriorate and have to return to the hospital, said Regan. This has been seen in many cases nationwide.

At least 110 patients from community hospitals, including Holy Cross, have been transferred to Rush University Medical Center, a large, well-equipped facility that has been touted as having been built for a pandemic.

Theyre really patients that otherwise, in all likelihood, would not survive at those hospitals, said Dr. Paul Casey, Rushs acting chief medical officer. The resources just arent the same. Nor is the ability within critical care to provide a lot of the life-saving therapies.

On April 6, when Mayor Lightfoot publicly announced that the coronavirus was disproportionately affecting the citys black residents, the virus had been in Chicago at least since January, and more than 100 people were dead. The majority were black.

When we talk about equity and inclusion, theyre not just nice notions, Lightfoot said at the time. They are an imperative that we must embrace as a city. And we see this even more urgently when we look at these numbers and this disparity. Its unacceptable. No one should think that this is OK.

That day, the city announced the Racial Equity Rapid Response Team in partnership with West Side United, with a goal to bring a hyper local public health strategy to targeted communities. In the weeks since, the team has held tele-town halls, delivered thousands of door hangers and postcards with targeted information, and distributed 60,000 masks for residents in the predominantly black communities of Austin, Auburn Gresham and South Shore.

Dr. Allison Arwady, the citys public health commissioner said in an interview that officials had worked behind the scenes to combat rumors that black people couldnt contract the coronavirus, reaching out to community and faith leaders on the South and West sides in February and March to let them know the city was seeing cases across all races.

Arwady said the department at first hoped to contain the spread. It had tracked the cases for weeks as the virus crept through the city, and then exploded. By the end of March, more than 40 Chicagoans had died from the virus, according to the county medical examiner data, though the city said its tally of deaths was less than half of that.

For the most part, Lightfoot has received plaudits for her handling of the pandemic. Illinois was one of the first states in the country to release statistics on COVID-19 deaths by race. Lightfoot herself has even become something of a national political star, with viral videos and memes of her urging residents to stay home. She also gave several high-profile interviews discussing the disproportionate impact of COVID-19 on black communities and emphasizing the importance of tracking demographic data.

The city also encountered some challenges. Early on, it found that up to 30% of the testing data it collected didnt list race. At the April 6 press conference, which came one day after a WBEZ news report detailed the death disparities, the city released a detailed race analysis. The city also issued a public health order mandating demographic data of COVID-19 cases be reported in hopes of being better able to track and assist individuals and communities falling victim to the coronavirus.

Still, to some in the community, the city appeared a step behind. Niketa Brar, co-founder and executive director at Chicago United for Equity, which advocates for racial equity in the city, said officials didnt do enough to engage the communities they knew would be hardest hit. As soon as the virus entered Chicago, she said, the city should have used racial, health and economic data to predict where it would take hold and then begin working with residents in those communities on how best to protect and support them. The Racial Equity Rapid Response Team was dispatched much later, she said.

Weve seen enough maps to know what the next map is going to look like, Brar said. And yet we consistently fail to engage those who are closest to the harm time and time again.

Lightfoot said in an interview Friday she believes the city responded robustly to the virus from the start.

Read this article:
The first 100: COVID-19 took black lives first. It didn't have to. - Peoria Journal Star

Read the Rest...

Global trade impact of the Coronavirus Regenerative Medicine Products Market: New Investment Opportunities Emerge To Augment Segments in Sector By…

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Global trade impact of the Coronavirus Regenerative Medicine Products Market: New Investment Opportunities Emerge To Augment Segments in Sector By…

The report on the Regenerative Medicine Products market provides a birds eye view of the current proceeding within the Regenerative Medicine Products market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Regenerative Medicine Products market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Regenerative Medicine Products market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

As per the presented market report, the global Regenerative Medicine Products market is projected to attain a CAGR growth of ~XX% during the assessment period and surpass a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Regenerative Medicine Products market hinges its hope on a range of factors including, emphasis on innovation by market players, surge in the investments pertaining to R&D activities, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2630513&source=atm

Competition Landscape

The report provides critical insights related to the business operations of prominent companies operating in the Regenerative Medicine Products market. The revenue generated, market presence of different companies, product range, and the financials of each company is included in the report.

Regional Landscape

The regional landscape section of the report provides resourceful insights related to the scenario of the Regenerative Medicine Products market in the key regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential of the Regenerative Medicine Products market in each region.

End-User Analysis

The report provides a detailed analysis of the various end-users of the Regenerative Medicine Products along with the market share, size, and revenue generated by each end-user.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Regenerative Medicine Products market is segmented into Cell Therapy Tissue Engineering Biomaterial Others

Segment by Application Dermatology Cardiovascular CNS Orthopedic Others

Global Regenerative Medicine Products Market: Regional Analysis The Regenerative Medicine Products market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Regenerative Medicine Products market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Regenerative Medicine Products Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Regenerative Medicine Products market include: Acelity DePuy Synthes Medtronic ZimmerBiomet Stryker MiMedx Group Organogenesis UniQure Cellular Dynamics International Osiris Therapeutics Vcanbio Gamida Cell Golden Meditech Cytori Therapeutics Celgene Vericel Corporation Guanhao Biotech Mesoblast Stemcell Technologes Bellicum Pharmaceuticals

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2630513&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2630513&licType=S&source=atm

See the original post:
Global trade impact of the Coronavirus Regenerative Medicine Products Market: New Investment Opportunities Emerge To Augment Segments in Sector By...

Read the Rest...

Demand for 2-Methylthiophene Product Proliferates Across the Globe amid COVID-19; ABC End-use Industry Faces Multifaceted Consequences – Cole of Duty

§ May 19th, 2020 § Filed under Nano Medicine Comments Off on Demand for 2-Methylthiophene Product Proliferates Across the Globe amid COVID-19; ABC End-use Industry Faces Multifaceted Consequences – Cole of Duty

A recent market study on the global 2-Methylthiophene market reveals that the global 2-Methylthiophene market is expected to reach a value of ~US$ XX by the end of 2029 growing at a CAGR of ~XX% during the forecast period (2019-2029).

The 2-Methylthiophene market study includes a thorough analysis of the overall competitive landscape and the company profiles of leading market players involved in the global 2-Methylthiophene market. Further, the presented study offers accurate insights pertaining to the different segments of the global 2-Methylthiophene market such as the market share, value, revenue, and how each segment is expected to fair post the COVID-19 pandemic.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2632613&source=atm

The following doubts are addressed in the market report:

Key Highlights of the 2-Methylthiophene Market Report

The presented report segregates the 2-Methylthiophene market into different segments to ensure the readers gain a complete understanding of the different aspects of the 2-Methylthiophene market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2632613&source=atm

Segmentation of the 2-Methylthiophene market

Competitive Outlook

This section of the report throws light on the recent mergers, collaborations, partnerships, and research and development activities within the 2-Methylthiophene market on a global scale. Further, a detailed assessment of the pricing, marketing, and product development strategies adopted by leading market players is included in the 2-Methylthiophene market report.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the 2-Methylthiophene market is segmented into Purity 98% Purity 99% Others

Segment by Application New Medicine Pesticide Intermediate Others

Global 2-Methylthiophene Market: Regional Analysis The 2-Methylthiophene market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the 2-Methylthiophene market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global 2-Methylthiophene Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global 2-Methylthiophene market include: TCI HBCChem Anvia Chemicals Alfa Chemistry 3B Scientific Apollo Scientific Acros Organics Waterstone Technology Pfaltz & Bauer J & K Scientific Meryer (Shanghai) Chemical Technology Kanto Chemical

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2632613&licType=S&source=atm

Read more here:
Demand for 2-Methylthiophene Product Proliferates Across the Globe amid COVID-19; ABC End-use Industry Faces Multifaceted Consequences - Cole of Duty

Read the Rest...

Liver cancer: awareness of hepatitis D must be raised – Mirage News

§ May 18th, 2020 § Filed under Nano Medicine Comments Off on Liver cancer: awareness of hepatitis D must be raised – Mirage News

A meta-analysis carried out by scientists from UNIGE and HUG shows that an infection with the hepatitis D virus, whose screening is often neglected, increases the risk of developing liver cancer threefold.

Microscopic image of hepatocellular carcinoma. DR

Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with HepatitisB, has so far been little studied. HepatitisD is one of the most dangerous forms of chronic viral hepatitis because of its possible progression to irreversible liver diseases (cancer and cirrhosis, in particular). Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma, a particularly aggressive and often fatal liver cancer. By conducting a systematic review of the literature and a meta-analysis of all available data, they demonstrated that people infected with HepatitisD have up to three times the risk of developing hepatocellular carcinoma compared to those infected only with HepatitisB. These results, to be read in the Journal of Hepatology, plead for systematic screening of HepatitisD in patients with HepatitisB in order, on the one hand, to better manage patients and, on the other hand, to better understand the real prevalence of the disease.

There are five types of hepatitis viruses, with very different manifestations and consequences. Hepatitis A and E cause acute infections that can be severe but transient. HepatitisB, C and D, however, can become chronic and cause liver dysfunction months or even years after infection. Although HepatitisC is now well treated, HepatitisB and especially D are still difficult to control. The most serious consequence of HepatitisB and D is hepatocellular carcinoma, explains Francesco Negro, Professor at the Department of Pathology and Immunology of UNIGE Faculty of Medicine and Head of the HUG Viropathology Unit. It was already known that co-infection of HepatitisB and D accelerates the progression of cirrhosis. However, to what extent co-infection of HepatitisB and D accelerates the progression towards this particularly aggressive liver cancer? This remained to be evaluated.

To find out whether HepatitisD is even more dangerous than B, we carried out a systematic review and meta-analysis of all epidemiological studies, explains Dulce Alfaiate, a researcher at the Department of Pathology and Immunology of UNIGE Faculty of Medicine and first author of this work. To do this, we re-examined the data presented in 93 studies, representing a total of more than 100,000 patients. Although not all these studies are of similar quality, the analysis of the best of them is very clear: patients with HepatitisD have an almost threefold risk of developing hepatocellular carcinoma compared to those with HepatitisB alone. Thats huge!

At least 15 million people infected worldwide

According to World Health Organization figures, hundreds of millions of people are infected with the HepatitisB virus. In some regions, such as Polynesia and some African countries, more than 6% of the adult population is infected and the virus is largely transmitted from mother to child. Moreover, children infected at birth almost always develop the chronic form of the disease.

The HepatitisD virus in turn infects a significant proportion of HepatitisB carriers, but the extent of the problem is unknown. Some estimates suggest that at least 15 to 20 million people are infected with HepatitisD, whereas other estimates may reach 60 million, almost double the number of people living with HIV worldwide, says Dulce Alfaiate. In the absence of systematic testing, however, it is extremely difficult to be precise. In Switzerland, an estimated 25,000 people live with HepatitisB, among whom 1,500 with HepatitisD. And this in spite of an available and effective HepatitisB vaccine.

A call for research

Apart from interferon, an antiviral and an immuno-modulator with limited effectiveness but with deleterious side effects, there is currently no treatment for HepatitisD. In our view, the evolution towards liver cancer is grossly underestimated, Francesco Negro points out. And yet, this disease affects young patients who suffer from cirrhosis as early as the age of 25-30 years.

Several ways of controlling the disease are currently being explored: Francesco Negros laboratory is studying the epigenetic changes induced by the virus and the mechanism of giving rise to liver tumours. The authors conclude: Our work underlines the need to improve HepatitisD screening in HepatitisB patients and the urgent need for effective antiviral therapies, such as the one against HepatitisC, which has saved the lives of millions of people since 2011.

See the rest here:
Liver cancer: awareness of hepatitis D must be raised - Mirage News

Read the Rest...

« Older Entries Newer Entries »



Page 4«..3456..1020..»